Cite

HARVARD Citation

    Daimon, S. et al. (2016). Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients. Renal replacement therapy. 2 (1), pp. 1-8. [Online]. 
  
Back to record